Rare diseases
Investigational molecules
Locations
379 conditions with trials, the busiest first
1 276 trials across Europe, recruiting first
Study on Mepolizumab and Nasal Polypectomy for Patients with Chronic Rhinosinusitis
SpainStudy on Baloxavir Marboxil for Children with Influenza
BulgariaStudy on Monitoring vs. Rivaroxaban for Patients with Low-Risk Isolated Subsegmental Pulmonary Embolism
BelgiumStudy of Pembrolizumab and Chemotherapy for Patients with Locally Advanced Sinonasal Carcinoma
ItalyStudy on Phenoxymethylpenicillin for Patients with Severe Streptococcus Group A-Negative Acute Tonsillitis
SwedenStudy on Anakinra for Patients with Long COVID and Ongoing Respiratory Symptoms
GermanyStudy on the Safety and Effectiveness of Zipalertinib for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer with Specific EGFR Mutations
FranceStudy on Advanced Laryngeal and Hypopharyngeal Cancer: Comparing Docetaxel, Cisplatin, and Pembrolizumab for Patients Eligible for Laryngectomy
GermanyStudy on Sotatercept for Children with Pulmonary Arterial Hypertension Receiving Standard Care
FranceStudy Comparing Telisotuzumab Vedotin and Docetaxel for Adults with Previously Treated Non-Squamous Non-Small Cell Lung Cancer
AustriaStudy on Durvalumab with Carboplatin or Cisplatin and Etoposide for First-Line Treatment in Patients with Extensive Stage Extrapulmonary Small Cell Carcinoma
ItalyStudy on Tezepelumab for Children Aged 5 to 11 with Severe Asthma
FranceThe therapies tested most often in Respiratory, thoracic and mediastinal disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
